Live
Endpoints NewsFDA greenlights Colorado's drug import proposalCellThe critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBMFierceBiotechPE firm Altaris scoops up AI drug development outfit Simulations Plus for $375MBioPharma DiveLilly buys non-opioid pain drugmaker 4EBioPharma DiveExpress Scripts, PCMA sue to block Tennesee law breaking up PBMs and pharmaciesBioWorldChinese challenger Gan & Lee gains momentum in metabolic diseaseBioWorldElixiron’s enrupatinib shows upbeat interim phase II AD resultsBioWorldChina partnerships drive biopharma’s biggest deal month since 2023BioWorldOricell brings first pivotal-stage CAR T in liver cancerBioWorldLaekna licenses LAE-118 ex-China to Vasque in $527M dealBioPharma DiveFDA staff scrutinizes evidence supporting Moderna’s flu vaccineEndpoints NewsEdgewise to advance heart drug into Phase 3 following mid-stage data update
Cet article n'est pas disponible dans les archives.